Factors influencing reproducibility of tumour regression grading after high-dose chemoradiation of locally advanced rectal cancer

Histopathology

Volumn 59, Issue 1, 2011, Pages 18-21

  Lindebjerg, Jan ^a   Hansborg, Niels ^a   Ploen, John ^a   Rafaelsen, Soren ^a   Jorgensen, Jens Christian Riis ^a   Jakobsen, Anders ^a  

^a LILLEBAELT HOSPITAL   (Denmark)

Author keywords

Chemoradiation; Rectal cancer; Reproducibility; Tumour regression grading

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; DISEASE SEVERITY; DRUG MEGADOSE; EPITHELIUM; FIBROSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MANDARD FIVE POINT GRADING SYSTEM; PRIORITY JOURNAL; PROGNOSIS; RECTUM CANCER; REPRODUCIBILITY; TREATMENT OUTCOME;

CHEMORADIOTHERAPY; FIBROSIS; HUMANS; NEOPLASM GRADING; OBSERVER VARIATION; RECTAL NEOPLASMS; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 79960450864     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03888.x     Document Type: Article

References (11)

1. Glimelius B, Oliveira J. ESMO Guidelines Working Group. Rectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann. Oncol. 2009; 20 (Suppl. 4); 54-56.
2. Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int. J. Colorect. Dis. 1997; 12; 19-23.
3. Bouzourene H, Bosman FT, Seelentag W, Matter M, Coucke P. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Cancer 2002; 15; 1121-1130.
4. Beddy D, Hyland JM, Winter DC et al. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy. Ann. Surg. Oncol. 2008; 15; 3471-3477.
5. Suárez J, Vera R, Balén E et al. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer. Colorect. Dis. 2008; 10; 563-568.
6. Ryan R, Gibbons D, Hyland JM et al. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology 2005; 47; 141-146.
7. Mandard AM, Dalibard F, Mandard JC et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 1994; 73; 2680-2686.
8. Morgan MJ, Koorey DJ, Painter D et al. Histological tumour response to pre-operative combined modality therapy in locally advanced rectal cancer. Colorect. Dis. 2002; 3; 177-183.
9. Bateman AC, Jaynes E, Bateman AR. Rectal cancer staging post neoadjuvant therapy - how should the changes be assessed. Histopathology 2009; 54; 713-721.
10. Rödel C, Martus P, Papadoupolos T et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J. Clin. Oncol. 2005; 23; 8688-8696.
11. Jakobsen A, Mortensen JP, Bisgaard C, Lindebjerg J, Hansen JW, Rafaelsen SR. Preoperative chemoradiation of locally advanced T3 rectal cancer combined with an endorectal boost. Int. J. Radiat. Oncol. Biol. Phys. 2006; 64; 461-465.